Table of Content

1 Neurologic Disorder Treatment Drug Market Scope Analysis Introduction
1.1 Neurologic Disorder Treatment Drug Product Definition and Scope Introduction
1.2 Neurologic Disorder Treatment Drug Market dynamics
1.3 Neurologic Disorder Treatment Drug Market Segmentation
1.3.1 Neurologic Disorder Treatment Drug Segment by Type
1.3.2 Neurologic Disorder Treatment Drug Segment by Applications
1.4 Report Timeline
2 Methodology and Data Source
2.1 Methodology/Research Approach
2.1.1 Research Programs/Design
2.1.2 Market Size Estimation
2.1.3 Market Breakdown and Data Triangulation
2.2 Data Source
2.2.1 Secondary Sources
2.2.2 Primary Sources
2.2.3 Legal Disclaimer
3 Analysis of key market players
3.1 AbbVie
3.1.1 Business Overview
3.1.2 Neurologic Disorder Treatment Drug Product Introduction
3.1.3 AbbVie Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
3.2 Acadia Pharmaceuticals
3.2.1 Business Overview
3.2.2 Neurologic Disorder Treatment Drug Product Introduction
3.2.3 Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
3.3 Acorda Therapeutics Biotechnology
3.3.1 Business Overview
3.3.2 Neurologic Disorder Treatment Drug Product Introduction
3.3.3 Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
3.4 Bayer
3.4.1 Business Overview
3.4.2 Neurologic Disorder Treatment Drug Product Introduction
3.4.3 Bayer Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
3.5 Biogen
3.5.1 Business Overview
3.5.2 Neurologic Disorder Treatment Drug Product Introduction
3.5.3 Biogen Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
3.6 CSK
3.6.1 Business Overview
3.6.2 Neurologic Disorder Treatment Drug Product Introduction
3.6.3 CSK Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
3.7 Eisai
3.7.1 Business Overview
3.7.2 Neurologic Disorder Treatment Drug Product Introduction
3.7.3 Eisai Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
3.8 F. Hoffmann La Roche
3.8.1 Business Overview
3.8.2 Neurologic Disorder Treatment Drug Product Introduction
3.8.3 F. Hoffmann La Roche Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
3.9 H Lundbeck
3.9.1 Business Overview
3.9.2 Neurologic Disorder Treatment Drug Product Introduction
3.9.3 H Lundbeck Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
3.10 Johnson and Johnson
3.10.1 Business Overview
3.10.2 Neurologic Disorder Treatment Drug Product Introduction
3.10.3 Johnson and Johnson Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
3.11 Merck
3.11.1 Business Overview
3.11.2 Neurologic Disorder Treatment Drug Product Introduction
3.11.3 Merck Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
3.12 Novartis
3.12.1 Business Overview
3.12.2 Neurologic Disorder Treatment Drug Product Introduction
3.12.3 Novartis Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
3.13 Otsuka Pharmaceutical
3.13.1 Business Overview
3.13.2 Neurologic Disorder Treatment Drug Product Introduction
3.13.3 Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
3.14 Pfizer
3.14.1 Business Overview
3.14.2 Neurologic Disorder Treatment Drug Product Introduction
3.14.3 Pfizer Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
3.15 Sanofi
3.15.1 Business Overview
3.15.2 Neurologic Disorder Treatment Drug Product Introduction
3.15.3 Sanofi Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
3.16 Takeda Pharmaceutical
3.16.1 Business Overview
3.16.2 Neurologic Disorder Treatment Drug Product Introduction
3.16.3 Takeda Pharmaceutical Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
3.17 Teva Pharmaceutical Industries
3.17.1 Business Overview
3.17.2 Neurologic Disorder Treatment Drug Product Introduction
3.17.3 Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
3.18 UCB
3.18.1 Business Overview
3.18.2 Neurologic Disorder Treatment Drug Product Introduction
3.18.3 UCB Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
3.19 USWM
3.19.1 Business Overview
3.19.2 Neurologic Disorder Treatment Drug Product Introduction
3.19.3 USWM Neurologic Disorder Treatment Drug Sales, Price, Revenue, Gross Margin
4 Neurologic Disorder Treatment Drug Historical and Forecast Market Size by Type
4.1 Neurologic Disorder Treatment Drug Market Historical Size by Type (2017-2022)
4.2 Neurologic Disorder Treatment Drug Market Forecast Size by Type (2023-2028)
5 Neurologic Disorder Treatment Drug Historical and Forecast Market Size by Application
5.1 Neurologic Disorder Treatment Drug Market Historical Size by Application (2017-2022)
5.2 Neurologic Disorder Treatment Drug Market Forecast Size by Application (2023-2028)
6 Neurologic Disorder Treatment Drug Historical and Forecast Market Size by Region
6.1 Neurologic Disorder Treatment Drug Historical and Forecast Sales Market Size by Region
6.2 Neurologic Disorder Treatment Drug Historical and Forecast Revenue Market Size by Region
6.3 Neurologic Disorder Treatment Drug Historical and Forecast Market Size by Country
6.3.1 Neurologic Disorder Treatment Drug Historical and Forecast Sales Market Size by Country (2017-2028)
6.3.1.1 United States Neurologic Disorder Treatment Drug Sales and Growth (2017-2028)
6.3.1.2 Canada Neurologic Disorder Treatment Drug Sales and Growth (2017-2028)
6.3.1.3 Germany Neurologic Disorder Treatment Drug Sales and Growth (2017-2028)
6.3.1.4 UK Neurologic Disorder Treatment Drug Sales and Growth (2017-2028)
6.3.1.5 France Neurologic Disorder Treatment Drug Sales and Growth (2017-2028)
6.3.1.6 Italy Neurologic Disorder Treatment Drug Sales and Growth (2017-2028)
6.3.1.7 Russia Neurologic Disorder Treatment Drug Sales and Growth (2017-2028)
6.3.1.5 China Neurologic Disorder Treatment Drug Sales and Growth (2017-2028)
6.3.1.6 Japan Neurologic Disorder Treatment Drug Sales and Growth (2017-2028)
6.3.1.7 Southeast Asia Neurologic Disorder Treatment Drug Sales and Growth (2017-2028)
6.3.1.8 Korea Neurologic Disorder Treatment Drug Sales and Growth (2017-2028)
6.3.1.9 India Neurologic Disorder Treatment Drug Sales and Growth (2017-2028)
6.3.1.10 Brazil Neurologic Disorder Treatment Drug Sales and Growth (2017-2028)
6.3.1.11 Mexico Neurologic Disorder Treatment Drug Sales and Growth (2017-2028)
6.3.2 Neurologic Disorder Treatment Drug Historical and Forecast Revenue Market Size by Country (2017-2028)
6.3.2.1 United States Neurologic Disorder Treatment Drug Revenue and Growth (2017-2028)
6.3.2.2 Canada Neurologic Disorder Treatment Drug Revenue and Growth (2017-2028)
6.3.2.3 Germany Neurologic Disorder Treatment Drug Revenue and Growth (2017-2028)
6.3.2.4 UK Neurologic Disorder Treatment Drug Revenue and Growth (2017-2028)
6.3.2.5 France Neurologic Disorder Treatment Drug Revenue and Growth (2017-2028)
6.3.2.6 Italy Neurologic Disorder Treatment Drug Revenue and Growth (2017-2028)
6.3.2.7 Russia Neurologic Disorder Treatment Drug Revenue and Growth (2017-2028)
6.3.2.5 China Neurologic Disorder Treatment Drug Revenue and Growth (2017-2028)
6.3.2.6 Japan Neurologic Disorder Treatment Drug Revenue and Growth (2017-2028)
6.3.2.7 Southeast Asia Neurologic Disorder Treatment Drug Revenue and Growth (2017-2028)
6.3.2.8 Korea Neurologic Disorder Treatment Drug Revenue and Growth (2017-2028)
6.3.2.9 India Neurologic Disorder Treatment Drug Revenue and Growth (2017-2028)
6.3.2.10 Brazil Neurologic Disorder Treatment Drug Revenue and Growth (2017-2028)
6.3.2.11 Mexico Neurologic Disorder Treatment Drug Revenue and Growth (2017-2028)
7 Neurologic Disorder Treatment Drug Market Dynamics
7.1 Market Drivers
7.2 Market Restraints
7.3 Opportunity
7.4 Market Trends
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Neurologic Disorder Treatment Drug Distributors List
8.3 Neurologic Disorder Treatment Drug Customers
9 Research Findings and Conclusion